Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
tai-screen-luciferase | 6.540 | 1.10e-144 | 1.18e-07 | 1.59e-03 |
Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | List-Gonzales GI | Tai-Hits |
---|---|---|---|---|---|---|---|
COPZ1 | 22818 | 32 | -8.301 | 9.063 | 13 | Yes | Yes |
COPA | 1314 | 32 | -9.395 | 9.063 | 170 | Yes | Yes |
RPS27A | 6233 | 15 | -5.631 | 8.389 | 342 | Yes | - |
TBL3 | 10607 | 2 | -3.692 | 7.486 | 102 | Yes | Yes |
[ COQ2 ] | 27235 | 1 | -2.044 | 6.540 | 44 | - | - |
ARCN1 | 372 | 32 | -8.232 | 9.063 | 118 | Yes | Yes |
COPB1 | 1315 | 22 | -6.221 | 9.063 | 118 | Yes | Yes |
COPB2 | 9276 | 32 | -13.168 | 9.063 | 41 | Yes | Yes |
LYPLA2 | 11313 | 1 | -2.172 | 6.540 | 10 | - | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
COPA | 1314 | COPB1 | 1315 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastHigh |
ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
ARCN1 | 372 | COPB1 | 1315 | pp | -- | int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, BIND, BIND_Yeast, HPRD, Krogan_Core, MIPS; int.HPRD: in vivo |
COPA | 1314 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
COPA | 1314 | TBL3 | 10607 | pp | -- | int.I2D: YeastLow |
TBL3 | 10607 | COQ2 | 27235 | pp | -- | int.I2D: BioGrid_Yeast, BIND_Yeast, MINT_Yeast, MIPS, YeastMedium, IntAct_Yeast |
ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
COPA | 1314 | COQ2 | 27235 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid |
LYPLA2 | 11313 | COQ2 | 27235 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastMedium; int.DIP: MI:0915(physical association) |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0030126 | COPI vesicle coat | 1.92e-14 | 2.76e-10 | 9.383 | 5 | 7 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 3.11e-14 | 4.49e-10 | 9.268 | 5 | 8 | 13 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.28e-12 | 1.85e-08 | 8.324 | 5 | 8 | 25 |
GO:0061024 | membrane organization | 7.63e-11 | 1.10e-06 | 6.051 | 6 | 12 | 145 |
GO:0006886 | intracellular protein transport | 2.68e-08 | 3.86e-04 | 5.550 | 5 | 7 | 171 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.14e-07 | 1.64e-03 | 8.144 | 3 | 4 | 17 |
GO:0005198 | structural molecule activity | 8.85e-05 | 1.00e+00 | 5.002 | 3 | 6 | 150 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0002083 | 4-hydroxybenzoate decaprenyltransferase activity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0047293 | 4-hydroxybenzoate nonaprenyltransferase activity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0005829 | cytosol | 1.39e-03 | 1.00e+00 | 1.946 | 6 | 61 | 2496 |
GO:0030157 | pancreatic juice secretion | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0006071 | glycerol metabolic process | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0006744 | ubiquinone biosynthetic process | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 |
GO:0005798 | Golgi-associated vesicle | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 |
GO:0032040 | small-subunit processome | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 10 |
GO:0008299 | isoprenoid biosynthetic process | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0019082 | viral protein processing | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 2 | 12 |
GO:0032479 | regulation of type I interferon production | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 13 |
GO:0030131 | clathrin adaptor complex | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 2 | 14 |
GO:0075733 | intracellular transport of virus | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 3 | 17 |
GO:0015935 | small ribosomal subunit | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 9 | 17 |
GO:0019068 | virion assembly | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 2 | 17 |
GO:0043473 | pigmentation | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 20 |
GO:0007220 | Notch receptor processing | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 22 |
GO:0016020 | membrane | 1.43e-02 | 1.00e+00 | 1.931 | 4 | 41 | 1681 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 25 |
GO:0043231 | intracellular membrane-bounded organelle | 1.57e-02 | 1.00e+00 | 3.333 | 2 | 5 | 318 |
GO:0005978 | glycogen biosynthetic process | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 26 |
GO:0032480 | negative regulation of type I interferon production | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 32 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 3 | 36 |
GO:0044822 | poly(A) RNA binding | 2.35e-02 | 1.00e+00 | 2.187 | 3 | 32 | 1056 |
GO:0005057 | receptor signaling protein activity | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 2 | 38 |
GO:0022627 | cytosolic small ribosomal subunit | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 20 | 39 |
GO:0006631 | fatty acid metabolic process | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 40 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 2.53e-02 | 1.00e+00 | 5.289 | 1 | 3 | 41 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.65e-02 | 1.00e+00 | 5.220 | 1 | 2 | 43 |
GO:0008344 | adult locomotory behavior | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 44 |
GO:0007254 | JNK cascade | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 3 | 49 |
GO:0030666 | endocytic vesicle membrane | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 2 | 53 |
GO:0051403 | stress-activated MAPK cascade | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 3 | 54 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 1 | 56 |
GO:0016197 | endosomal transport | 3.50e-02 | 1.00e+00 | 4.813 | 1 | 3 | 57 |
GO:0016787 | hydrolase activity | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 1 | 58 |
GO:0032481 | positive regulation of type I interferon production | 3.74e-02 | 1.00e+00 | 4.715 | 1 | 3 | 61 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 3.74e-02 | 1.00e+00 | 4.715 | 1 | 2 | 61 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 6 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 6 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 4 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 4 | 65 |
GO:0016032 | viral process | 4.14e-02 | 1.00e+00 | 2.585 | 2 | 33 | 534 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 8 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 4.35e-02 | 1.00e+00 | 4.496 | 1 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 4.35e-02 | 1.00e+00 | 4.496 | 1 | 4 | 71 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 6 | 72 |
GO:0034162 | toll-like receptor 9 signaling pathway | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 4 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 4.47e-02 | 1.00e+00 | 4.456 | 1 | 4 | 73 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 8 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 6 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 4 | 76 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 4 | 78 |
GO:0005179 | hormone activity | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 1 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 8 | 79 |
GO:0034138 | toll-like receptor 3 signaling pathway | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 4 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 4 | 80 |
GO:0019083 | viral transcription | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 20 | 81 |
GO:0050852 | T cell receptor signaling pathway | 5.18e-02 | 1.00e+00 | 4.237 | 1 | 2 | 85 |
GO:0005794 | Golgi apparatus | 5.28e-02 | 1.00e+00 | 2.393 | 2 | 9 | 610 |
GO:0006415 | translational termination | 5.30e-02 | 1.00e+00 | 4.203 | 1 | 20 | 87 |
GO:0000187 | activation of MAPK activity | 5.48e-02 | 1.00e+00 | 4.154 | 1 | 2 | 90 |
GO:0071456 | cellular response to hypoxia | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 3 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 6 | 92 |
GO:0006414 | translational elongation | 5.66e-02 | 1.00e+00 | 4.107 | 1 | 20 | 93 |
GO:0006364 | rRNA processing | 5.72e-02 | 1.00e+00 | 4.092 | 1 | 7 | 94 |
GO:0034142 | toll-like receptor 4 signaling pathway | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 4 | 96 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 6.31e-02 | 1.00e+00 | 3.946 | 1 | 20 | 104 |
GO:0002224 | toll-like receptor signaling pathway | 6.60e-02 | 1.00e+00 | 3.878 | 1 | 4 | 109 |
GO:0097190 | apoptotic signaling pathway | 6.84e-02 | 1.00e+00 | 3.826 | 1 | 3 | 113 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.89e-02 | 1.00e+00 | 3.813 | 1 | 20 | 114 |
GO:0019058 | viral life cycle | 6.95e-02 | 1.00e+00 | 3.801 | 1 | 23 | 115 |
GO:0000209 | protein polyubiquitination | 7.01e-02 | 1.00e+00 | 3.788 | 1 | 7 | 116 |
GO:0006006 | glucose metabolic process | 7.13e-02 | 1.00e+00 | 3.764 | 1 | 3 | 118 |
GO:0007219 | Notch signaling pathway | 7.25e-02 | 1.00e+00 | 3.739 | 1 | 3 | 120 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 7.48e-02 | 1.00e+00 | 3.692 | 1 | 3 | 124 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 7.71e-02 | 1.00e+00 | 3.646 | 1 | 3 | 128 |
GO:0006413 | translational initiation | 7.89e-02 | 1.00e+00 | 3.613 | 1 | 21 | 131 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.18e-02 | 1.00e+00 | 3.559 | 1 | 5 | 136 |
GO:0003735 | structural constituent of ribosome | 8.23e-02 | 1.00e+00 | 3.548 | 1 | 22 | 137 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 3 | 145 |
GO:0034220 | ion transmembrane transport | 8.92e-02 | 1.00e+00 | 3.427 | 1 | 2 | 149 |
GO:0000082 | G1/S transition of mitotic cell cycle | 8.92e-02 | 1.00e+00 | 3.427 | 1 | 9 | 149 |
GO:0042981 | regulation of apoptotic process | 8.98e-02 | 1.00e+00 | 3.417 | 1 | 7 | 150 |
GO:0010008 | endosome membrane | 9.04e-02 | 1.00e+00 | 3.408 | 1 | 5 | 151 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 9.33e-02 | 1.00e+00 | 3.361 | 1 | 3 | 156 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 1.00e-01 | 1.00e+00 | 3.254 | 1 | 3 | 168 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 3 | 184 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.12e-01 | 1.00e+00 | 3.084 | 1 | 4 | 189 |
GO:0019221 | cytokine-mediated signaling pathway | 1.30e-01 | 1.00e+00 | 2.858 | 1 | 2 | 221 |
GO:0016071 | mRNA metabolic process | 1.31e-01 | 1.00e+00 | 2.845 | 1 | 25 | 223 |
GO:0006412 | translation | 1.35e-01 | 1.00e+00 | 2.801 | 1 | 23 | 230 |
GO:0016070 | RNA metabolic process | 1.44e-01 | 1.00e+00 | 2.698 | 1 | 25 | 247 |
GO:0005975 | carbohydrate metabolic process | 1.47e-01 | 1.00e+00 | 2.663 | 1 | 3 | 253 |
GO:0006281 | DNA repair | 1.52e-01 | 1.00e+00 | 2.618 | 1 | 4 | 261 |
GO:0043065 | positive regulation of apoptotic process | 1.55e-01 | 1.00e+00 | 2.580 | 1 | 6 | 268 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.56e-01 | 1.00e+00 | 2.575 | 1 | 4 | 269 |
GO:0005743 | mitochondrial inner membrane | 1.60e-01 | 1.00e+00 | 2.532 | 1 | 2 | 277 |
GO:0044281 | small molecule metabolic process | 1.71e-01 | 1.00e+00 | 1.404 | 2 | 15 | 1211 |
GO:0035556 | intracellular signal transduction | 1.74e-01 | 1.00e+00 | 2.403 | 1 | 4 | 303 |
GO:0070062 | extracellular vesicular exosome | 1.78e-01 | 1.00e+00 | 1.002 | 3 | 40 | 2400 |
GO:0005737 | cytoplasm | 1.87e-01 | 1.00e+00 | 0.767 | 4 | 43 | 3767 |
GO:0000139 | Golgi membrane | 2.04e-01 | 1.00e+00 | 2.150 | 1 | 6 | 361 |
GO:0000278 | mitotic cell cycle | 2.19e-01 | 1.00e+00 | 2.035 | 1 | 11 | 391 |
GO:0043066 | negative regulation of apoptotic process | 2.36e-01 | 1.00e+00 | 1.918 | 1 | 13 | 424 |
GO:0055085 | transmembrane transport | 2.41e-01 | 1.00e+00 | 1.881 | 1 | 3 | 435 |
GO:0044267 | cellular protein metabolic process | 2.60e-01 | 1.00e+00 | 1.757 | 1 | 23 | 474 |
GO:0006915 | apoptotic process | 2.98e-01 | 1.00e+00 | 1.530 | 1 | 9 | 555 |
GO:0005783 | endoplasmic reticulum | 2.98e-01 | 1.00e+00 | 1.527 | 1 | 3 | 556 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.04e-01 | 1.00e+00 | 1.491 | 1 | 7 | 570 |
GO:0045087 | innate immune response | 3.16e-01 | 1.00e+00 | 1.427 | 1 | 8 | 596 |
GO:0010467 | gene expression | 3.48e-01 | 1.00e+00 | 1.260 | 1 | 29 | 669 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.97e-01 | 1.00e+00 | 1.022 | 1 | 6 | 789 |
GO:0005615 | extracellular space | 4.61e-01 | 1.00e+00 | 0.744 | 1 | 2 | 957 |
GO:0005886 | plasma membrane | 4.98e-01 | 1.00e+00 | 0.312 | 2 | 20 | 2582 |
GO:0005654 | nucleoplasm | 5.04e-01 | 1.00e+00 | 0.567 | 1 | 15 | 1082 |
GO:0046872 | metal ion binding | 5.75e-01 | 1.00e+00 | 0.294 | 1 | 10 | 1307 |
GO:0006351 | transcription, DNA-templated | 6.14e-01 | 1.00e+00 | 0.148 | 1 | 6 | 1446 |
GO:0005730 | nucleolus | 6.63e-01 | 1.00e+00 | -0.034 | 1 | 24 | 1641 |
GO:0016021 | integral component of membrane | 7.36e-01 | 1.00e+00 | -0.307 | 1 | 5 | 1982 |
GO:0005515 | protein binding | 9.43e-01 | 1.00e+00 | -0.910 | 2 | 62 | 6024 |
GO:0005634 | nucleus | 9.67e-01 | 1.00e+00 | -1.508 | 1 | 43 | 4559 |